![Rajesh J. Asarpota](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rajesh J. Asarpota
Financieel Directeur/CFO bij
MARAVAI LIFESCIENCES HOLDINGS, INC.
Vermogen: 3 M $ op 30-06-2026
Profiel
Rajesh J.
Asarpota is currently an Independent Director at Profusa, Inc. starting in 2025 and Chief Financial Officer & Executive VP at Maravai Lifesciences Holdings, Inc. starting in 2025.
Former positions include Principal at GE Aerospace in 2004, Vice President-Finance at Life Technologies, Inc. from 2004 to 2014, Senior VP, Chief Financial & Accounting Officer at Questcor Pharmaceuticals, Inc. in 2014, Chief Financial Officer at Imaging Advantage LLC, Chief Operating & Financial Officer at Antylia Scientific, Chief Financial Officer & Executive Vice President at NuVasive LLC from 2017 to 2020, and Chief Financial Officer at Augmedics, Inc. from 2021 to 2025.
Education includes an MBA from Marquette University and an undergraduate degree from the University of Mumbai.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2026 | 434.416 ( 0,29% ) | 3 M $ | 30-06-2026 |
Actieve functies van Rajesh J. Asarpota
| Bedrijven | Functie | Begin |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Financieel Directeur/CFO | 30-06-2025 |
Eerdere bekende functies van Rajesh J. Asarpota
| Bedrijven | Functie | Einde |
|---|---|---|
Augmedics, Inc.
 Augmedics, Inc. Medical SpecialtiesHealth Technology Develops augmented-reality surgical visualization system | Financieel Directeur/CFO | 01-06-2025 |
| NUVASIVE, INC. | Financieel Directeur/CFO | 01-12-2020 |
| QUESTCOR PHARMACEUTICALS INC | Financieel Directeur/CFO | 01-08-2014 |
Life Technologies, Inc.
 Life Technologies, Inc. BiotechnologyHealth Technology Develops, manufactures and supplies products used for life science research | Financieel Directeur/CFO | 01-01-2014 |
| GE AEROSPACE | Corporate Officer/Principal | 01-04-2004 |
Opleiding van Rajesh J. Asarpota
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
82
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
GE Aerospace
 GE Aerospace Aerospace & DefenseElectronic Technology Designs, develops, manufactures and services aircraft engines for commercial airframes & defense jet engines, avionics & power systems | Electronic Technology |
Life Technologies, Inc.
Life Technologies, Inc. BiotechnologyHealth Technology Develops, manufactures and supplies products used for life science research | Health Technology |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
Imaging Advantage LLC
 Imaging Advantage LLC Medical/Nursing ServicesHealth Services Provides medical imaging services | Health Services |
Cole-Parmer Instrument Co. LLC
 Cole-Parmer Instrument Co. LLC Medical SpecialtiesHealth Technology Manufactures and distributes laboratory staples | Health Technology |
Marquette University
 Marquette University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Augmedics, Inc.
Augmedics, Inc. Medical SpecialtiesHealth Technology Develops augmented-reality surgical visualization system | Health Technology |
Maravai Lifesciences Holdings, Inc.
 Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
